Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.54 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.50 |
| ▸ | CALCR | P30988 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30163405 | 0.88 | OPRM1 (0.56) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL30163225 | 0.87 | KEAP1 (0.54) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL16352049 | 0.87 | KEAP1 (0.54) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL30163263 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL30163248 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL28210612 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL28846618 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL29597272 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL15130591 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1OPRK1RAMP3CALCR | |
| SCHEMBL14549930 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1OPRK1RAMP3CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022115799-A1 | RADIOPHARMACEUTICAL CONJUGATES TARGETING GUANYLYL CYCLASE C, AND COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. (US) | 2022-06-02 | — | — | WO | disclosed |